RxDoctor Payments Data

James Meade, MD

Sports Medicine · Watertown, WINPI 1528065257

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $170 of the $254 with a category attached, or 67.0%. 7 manufacturers reported payments, led by AbbVie at 28.9% of the total. 2025 is the largest year on record at $71, 6.3 times the $11 reported in 2019. That places this record below the midpoint for sports medicine clinicians in WI, where the typical reported total is $350.

$254in general payments, 2019–2025

Across 13 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$73
  • Novo Nordisk$71
  • Supernus Pharmaceuticals, Inc.$38
  • Insulet Corporation$27
  • Sanofi-aventis U.S. LLC$20
  • Genentech USA, Inc.$13
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$17067%
  • Education$8433%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$254 in reported general payments places this provider in the 45th percentile of 93 sports medicine providers in Wisconsin.

See all sports medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$145,153
Medicare patients
338
Services billed
11,934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban162$150,824
OzempicSemaglutide60$71,575
TrulicityDulaglutide62$65,977
FarxigaDapagliflozin Propanediol64$52,539
OxycontinOxycodone Hcl26$31,218
Xtampza ErOxycodone Myristate27$24,732
MounjaroTirzepatide20$19,885
XareltoRivaroxaban11$17,577
Nurtec OdtRimegepant Sulfate12$13,734
Breo ElliptaFluticasone/Vilanterol24$13,649
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$12,541
Daptomycin11$11,045
JanuviaSitagliptin Phosphate13$7,069
Repatha SureclickEvolocumab12$6,943
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$5,559

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$71$71,57560 claims
AstraZenecaFarxiga$12$52,53964 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 93 sports medicine providers in Wisconsin.

Other sports medicine in Watertown

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →